| 1. |
Fonseca AL, Cha CH. Hepatocellular carcinoma: a comprehensive overview of surgical therapy. J Surg Oncol, 2014, 110(6): 712-719.
|
| 2. |
Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol, 2014, 5(5): 374-387.
|
| 3. |
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery, 1990, 107(5): 521-527.
|
| 4. |
van den Esschert JW, van Lienden KP, Alles LK, et al. Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model. Ann Surg, 2012, 255(2): 311-318.
|
| 5. |
Wilms C, Mueller L, Lenk C, et al. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg, 2008, 247(5): 825-834.
|
| 6. |
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414.
|
| 7. |
王志明, 陶一明, 黃云, 等. 聯合肝臟離斷和門靜脈切斷二步肝切除術在肝炎后肝硬化肝癌中的應用. 中國普通外科雜志, 2014, 23(7): 867-872.
|
| 8. |
劉允怡, 劉曉欣. 對“聯合肝臟離斷和門靜脈結扎的二步肝切除術”的述評. 中華消化外科雜志, 2013, 12(7): 481-484.
|
| 9. |
Schadde E, Ardiles V, Slankamenac K, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg, 2014, 38(6): 1510-1519.
|
| 10. |
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg, 2014, 260(5): 829-836.
|
| 11. |
Huch M, Dorrell C, Boj SF, et al. In vitro expansion of single Lgr5 + liver stem cells induced by Wnt-driven regeneration. Nature, 2013, 494(7436): 247-250.
|
| 12. |
Leushacke M, Tan SH, Wong A, et al. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat Cell Biol, 2017, 19(7): 774-786.
|
| 13. |
Yao L, Li C, Ge X, et al. Establishment of a rat model of portal vein ligation combined with in situ splitting. PLoS One, 2014, 9(8): e105511.
|
| 14. |
Earl TM, Chapman WC. Conventional surgical treatment of hepatocellular carcinoma. Clin Liver Dis, 2011, 15(2): 353-370.
|
| 15. |
郭之野. 中晚期肝細胞肝癌的靶向治療: 困境與希望. 中國普通外科雜志, 2017, 26(1): 109-115.
|
| 16. |
Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology, 2001, 34(2): 267-272.
|
| 17. |
de Santiba?es E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg, 2012, 255(3): 415-417.
|
| 18. |
林為東. ALPPS 促進剩余肝臟快速增生機制及相關因素研究進展. 中國普通外科雜志, 2017, 26(8): 1065-1070.
|
| 19. |
段睿男, 王瑞峰. ALPPS 術后殘余肝臟的再生和 CD31 的表達變化的研究. 哈爾濱醫科大學學報, 2019, 53(6): 580-583.
|
| 20. |
Zhao L, Dai C, Gong Q. Changes of Endocan and its effect on hepatic stem cells during the rapid proliferation process of residual liver after ALPPS procedure. Cell Biochem Funct, 2020, 38(6): 817-825.
|
| 21. |
Tomassini F, D’Asseler Y, Giglio MC, et al. Hemodynamic changes in ALPPS influence liver regeneration and function: Results from a prospective study. HPB (Oxford), 2019, 21(5): 557-565.
|
| 22. |
McDonald T, Wang R, Bailey W, et al. Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem Biophys Res Commun, 1998, 247(2): 266-270.
|
| 23. |
Kumar KK, Burgess AW, Gulbis JM. Structure and function of LGR5: an enigmatic G-protein coupled receptor marking stem cells. Protein Sci, 2014, 23(5): 551-565.
|
| 24. |
Plaks V, Brenot A, Lawson DA, et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep, 2013, 3(1): 70-78.
|
| 25. |
Shimokawa M, Ohta Y, Nishikori S, et al. Visualization and targeting of LGR5+ human colon cancer stem cells. Nature, 2017, 545(7653): 187-192.
|
| 26. |
de Sousa e Melo F, Kurtova AV, Harnoss JM, et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature, 2017, 543(7647): 676-680.
|
| 27. |
Lin Y, Fang ZP, Liu HJ, et al. HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells. Nat Commun, 2017, 8(1): 1175.
|
| 28. |
Schneeberger K, Sánchez-Romero N, Ye S, et al. Large-scale production of LGR5-positive bipotential human liver stem cells. Hepatology, 2020, 72(1): 257-270.
|
| 29. |
Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology, 1990, 17(6): 489-503.
|
| 30. |
Gerlach C, Sakkab DY, Scholzen T, et al. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology, 1997, 26(3): 573-578.
|
| 31. |
Kuijk EW, Rasmussen S, Blokzijl F, et al. Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure. Sci Rep, 2016, 6: 22154.
|
| 32. |
劉偉偉, 余鋒, 劉洪, 等. 大鼠 ALPPS 術后殘肝再生與 Wnt2 蛋白表達關系的研究. 安徽醫科大學學報, 2017, 52(9): 1331-1335.
|